Sonendo® to Present at Stifel Investor Conference

Print
| Source: Sonendo

LAGUNA HILLS, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Bjarne Bergheim, President and Chief Executive Officer of Sonendo® Inc., will be presenting at the 2017 Stifel Health Care Conference. The conference is slated to be held in New York City on Tuesday, November 14. The presentation will begin at 2:00 p.m. Eastern Time.

About the event, Sonendo CEO Bjarne Bergheim said, “It is an honor to be asked to be a presenter at this year’s conference. Sonendo’s mission to save teeth is key to improving the quality of life for patients in need of endodontic therapy, and the GentleWave® System offers patients a superior alternative to standard root canal treatment. The GentleWave Procedure presents the endodontist with the opportunity to expand their referral base by providing better clinical results and a better experience for patients. As we see it, the Sound Science® technology in the GentleWave System is not only a sound investment for a patient’s health, it is also a sound investment for the financial health and success of an endodontic practice.”

About Sonendo
Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science. The first commercially available product from Sonendo, the GentleWave System, available in the US, shows significant improvements in clinical efficacy and treatment efficiency when compared to standard root canal techniques.1,2 For more information, please visit www.sonendo.com

1Sigurdsson A et al. (2016) J Endod. 42:1040-48.  2Molina B et al. (2015) J Endod. 41:1701-05.

Forward-Looking Statements
This announcement contains forward-looking statements based on management's beliefs, assumptions and expectations and information currently available to management. All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities. Management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made. Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise. Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

  

Media Contact:
Bob Guyatt
Vice President of Marketing
949.766.3636